Black Diamond Therapeutics, Inc. 10-Q filing
Filed 2026-05-07 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001701541-26-000017
- Form type
- 10-Q
- CIK
- 0001701541
- Primary document
- https://www.sec.gov/Archives/edgar/data/1701541/000170154126000017/bdtx-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Black Diamond Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-11.3M | - | - |
| Net Income | $-9.0M | - | - |
| Eps Basic | -0.16 | - | - |
| Eps Diluted | -0.16 | - | - |
| Cash And Equivalents | $30.1M | - | - |
| Total Assets | $132.9M | - | - |
| Total Liabilities | $28.6M | - | - |
| Shareholders Equity | $104.3M | - | - |
| Operating Cash Flow | $-10.2M | - | - |